Home  >  Products  >  TNIP1 (TNFAIP3 interacting protein 1 ) Blocking Peptide (the C terminal of TNIP1)(100ug)
TNIP1 (TNFAIP3 interacting protein 1 ) Blocking Peptide (the C terminal of TNIP1)(100ug)

TNIP1 (TNFAIP3 interacting protein 1 ) Blocking Peptide (the C terminal of TNIP1)(100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-TNIP1 Antibody (ARP61714_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Reactivities: Human
Presku: AAP61714
Size: 100ug
Weight: 70kDa
Gene: The peptide is characterized by mass spectroscopy
Format: Lyophilized powder
Target: TNIP1 interacts with zinc finger protein A20/TNFAIP3 and inhibits TNF-induced NF-kappa-B-dependent gene expression by interfering with an RIP- or TRAF2-mediated transactivation signal. TNIP1 increases cell surface CD4(T4) antigen expression. TNIP1 interacts with HIV-1 matrix protein and is packaged into virions and overexpression can inhibit viral replication. TNIP1 may regulate matrix nuclear localization, both nuclear import of PIC (Preintegration complex) and export of GAG polyprotein and viral genomic RNA during virion production.
Alternative names: ABIN-1; KIAA0113; NAF1; VAN
See Full Product Listings >